SEC Form 4 · accession 0001179110-15-010132
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Bishop
Officer — Senior VP, Pharmaceutical Scie
Period of report
Jun 19, 2015
Accepted (ET)
Jun 22, 2015 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 19, 2015 | M | 2,554 | $15.44 | A | 101,934 | D | |
| Common Stock | Jun 19, 2015 | S | 2,554 | $25.50 | D | 99,380 | D | |
| Common Stock | Jun 19, 2015 | M | 18,720 | $15.44 | A | 118,100 | D | |
| Common Stock | Jun 19, 2015 | S | 18,720 | $25.50 | D | 99,380 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $15.44 | Jun 19, 2015 | M | 2,554 | D | Feb 14, 2015 | Feb 14, 2022 | Common Stock | 2,554 | 18,720 | D |
| Stock Option (Right to Buy) | $15.44 | Jun 19, 2015 | M | 18,720 | D | Feb 14, 2015 | Feb 14, 2022 | Common Stock | 18,720 | 0 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2013.